Inside Novavax lab amid race to develop Covid vaccine

Promising early results secured Novavax a $1.6 billion contract from Operation Warp Speed to produce 100 million doses of its Covid-19 vaccine effort. They hope to seek emergency use authorization in May. Pre-pandemic, the company was sinking and suffering setbacks after several failed phase three trials for other types of vaccines.March 23, 2021